IP Library › Granted Patent US 7,456,169
Granted Patent B2
US 7,456,169 · App. 11/466,638 · Granted Nov 25, 2008

Heterocyclic kinase inhibitors

Assignee: Abbott Laboratories Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,456,169
App. No.
11/466,638
Granted
Nov 25, 2008
Kind
B2
Abstract

Compounds having the formula are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

Claims (2)

1. A pharmaceutical composition comprising 2-[3-(3-methoxy-4-nitrophenyl)- 11 -oxo- 10,11 -dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl]-2-methyl-N-(4-morpholin-4-ylphenyl)propanamide, or a therapeutically acceptable salt thereof in combination with a therapeutically acceptable carrier.

2. The compound 2-[3-(3-methoxy-4-nitrophenyl)-11 -oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl]-2-methyl-N-(4-morpholin-4-ylphenyl)propanamide, or a therapeutically acceptable salt thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030176/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2007
From: HASVOLD, LISA A; HEXAMER, LAURA; LI, GAOQUAN; LIN, NAN-HORNG; SHAM, HING; SOWIN, THOMAS J; SULLIVAN, GERARD M; WANG, LE; XIA, PING
To: ABBOTT LABORATORIES
Reel/Frame 019274/0570 →
Continuity (3)
Continuation In Part 1078512000 · Feb 25, 2004
Provisional Application 6045047600 · Feb 27, 2003
Related Publication 20070254867A1 · Nov 1, 2007